MicroRNA‐21 as a predictor and prognostic factor for trastuzumab therapy in human epidermal growth factor receptor 2‐positive metastatic breast cancer
Author:
Affiliation:
1. Department of Medical Biochemistry and Molecular Biology, Faculty of Medicine Ain Shams University Cairo Egypt
2. Clinical Oncology and Nuclear Medicine Department, Faculty of Medicine Ain Shams University Cairo Egypt
Funder
Ain Shams University, Faculty of medicine
Publisher
Wiley
Subject
Cell Biology,Molecular Biology,Biochemistry
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1002/jcb.27620
Reference29 articles.
1. 2017 American Cancer Society American Cancer Society Breast cancer
2. 2018 National Cancer Institute of the USA National Cancer Institute of the USA Cancer statistics
3. Breast cancer chapter;Ferri's Clinical Advisor,2018
4. Metastatic breast cancer: the potential of miRNA for diagnosis and treatment monitoring
5. The HER2 Receptor in Breast Cancer: Pathophysiology, Clinical Use, and New Advances in Therapy
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Intraoperative radiotherapy in breast cancer: Alterations to the tumor microenvironment and subsequent biological outcomes (Review);Molecular Medicine Reports;2023-10-25
2. MicroRNA based combinatorial therapy against TKIs resistant CML by inactivating the PI3K/Akt/mTOR pathway: a review;Medical Oncology;2023-09-15
3. Plasma microRNA-195, −34c, and − 1246 as novel biomarkers for the diagnosis of trastuzumab-resistant HER2-positive breast cancer patients;Toxicology and Applied Pharmacology;2023-09
4. microRNAs signature in relapse metastasis and de novo metastasis of breast cancer. A systematic review;Critical Reviews in Oncology/Hematology;2023-08
5. In situ detection of exosomal RNAs for cancer diagnosis;Acta Biomaterialia;2023-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3